Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metformin pharmacokinetics in acute and chronic heart failure
2016-001513-25Phase 4Terminated
- Sponsor
- Aarhus University Hospital
- Start
- Apr 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of metformin in Acute Heart Failure (AHF), chronic heart failure (CHF) and type 2 diabetes mellitus (T2DM), sponsored by Aarhus University Hospital. Primary endpoint: Metformin pharmacokinetics in acute and chronic heart failure (Substudy A primary endpoint). Started Apr 2016; status: terminated.
02
Drugs
metformin
03
Conditions
Acute Heart Failure (AHF)chronic heart failure (CHF)type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on 2016-001513-25.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2016-001513-25.